Amy L. Ronneberg

Insider Reports History

Entity
Individual
Location
225 South 6 Th Street, 9 Th Floor, Minneapolis, Minnesota
Signature
/s/ Paul Lytle, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amy L. Ronneberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACTUATE THERAPEUTICS, INC. Director Non-Qualified Stock Options 30K Aug 12, 2024 Direct
Magenta Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 28, 2022 Direct

Insider Reports Filed by Amy L. Ronneberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 1 $0 4 Aug 14, 2024 Director
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 3 Aug 14, 2024 Director
MGTA Magenta Therapeutics, Inc. Jun 28, 2022 1 $0 4 Jun 30, 2022 Director
MGTA Magenta Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director